PIK3CA and colorectal carcinoma: Although it has a strong function in inhibiting PI3K with a tiny dose in vitro, caution should still be taken when considering developing it into CRC therapies, particularly with respect to toxicity, drug resistance, combination treatments, and specific PI3K isoforms.